Regular Article
Gaucher Disease and Parkinsonism: A Phenotypic and Genotypic Characterization

https://doi.org/10.1006/mgme.2001.3201Get rights and content

Abstract

Among the many phenotypes associated with Gaucher disease, the inherited deficiency of glucocerebrosidase, are reports of patients with parkinsonian symptoms. The basis for this association is unknown, but could be due to alterations in the gene or gene region. The human glucocerebrosidase gene, located on chromosome 1q21, has a nearby pseudogene that shares 96% identity. Immediately adjacent to the glucocerebrosidase pseudogene is a convergently transcribed gene, metaxin, which has a pseudogene that is located just downstream to the glucocerebrosidase gene. We describe a patient with mild Gaucher disease but impaired horizontal saccadic eye movements who developed a tremor at age 42, followed by rapid deterioration of her gait. A pallidotomy at age 47 was unsuccessful. Her motor and cognitive deterioration progressed despite enzyme replacement therapy. Sequencing of the glucocerebrosidase gene identified mutations L444P and D409H. Southern blot analysis using the enzyme SspI showed that the maternal allele had an additional 17-kb band. PCR amplifications and sequencing of this fragment demonstrated a duplication which included the glucocerebrosidase pseudogene, metaxin gene, and a pseudometaxin/metaxin fusion. Gene alterations associated with this novel rearrangement, resulting from a crossover between the gene for metaxin and its pseudogene, could contribute to the atypical phenotype encountered in this patient.

References (46)

  • KM Dipple et al.

    Modifier genes convert “simple” Mendelian disorders to complex traits

    Mol Genet Metab

    (2000)
  • CR Scriver et al.

    Monogenic traits are not simple: lessons from phenylketonuria

    Trends Genet

    (1999)
  • KM Dipple et al.

    Phenotypes of patients with “simple” mendelian disorders are complex traits: Thresholds, modifiers and systems dynamics

    Am J Hum Genet

    (2000)
  • J Vockley et al.

    Synergistic heterozygosity: Disease resulting from multiple partial defects in one or more metabolic pathways

    Mol Genet Metab

    (2000)
  • E Beutler et al.

    Glucosylceramide lipidoses

  • DS Frederickson et al.

    Glucosylceramide lipidoses: Gaucher's disease

  • RP Grewal et al.

    Neurologic complications of nonneuronopathic Gaucher's disease

    Arch Neurol

    (1991)
  • L vanBogaert et al.

    Un cas de maladie de Gaucher de l'adulte avec syndrome de Raynaud, pigmentation, et rigidite du type extra-pyramidal aux membres inferieurs

    Ann Med

    (1939)
  • GH Sack

    Clinical diversity in Gaucher's disease

    Johns Hopkins Med J

    (1980)
  • RO McKeran et al.

    Neurological involvement in type 1 (adult) Gaucher's disease

    J Neurol Neurosurg Psychiatry

    (1985)
  • SG Sun

    Chung Hua Shen Ching Chung Shon Ko Tsa Chih

    Medicine

    (1986)
  • JC Turpin et al.

    Parkinsonian symptomatology in a patient with type I (adult) Gaucher's disease

  • Cited by (179)

    • Pathways of protein synthesis and degradation in PD pathogenesis

      2020, Progress in Brain Research
      Citation Excerpt :

      Lysosomal degradation through either autophagy or CMA thus appears to modulate intracellular levels of α-synuclein protein, and disruption of these pathways may contribute to pathogenic accumulation of α-synuclein in PD. Interest in involvement of the lysosome in Parkinson's disease pathophysiology further grew from reports of a subset of patients with Gaucher's disease (GD), an inherited lysosomal storage disorder (LSD), who presented with Parkinsonian symptoms including bradykinesia, tremor, and rigidity (Machaczka et al., 1999; Neudorfer et al., 1996; Tayebi et al., 2001). Additionally, neuropathological exam of Gaucher's patients with parkinsonism features revealed synuclein-positive Lewy bodies (Tayebi et al., 2003).

    View all citing articles on Scopus
    1

    To whom correspondence should be addressed. Fax: (301) 402-6438. E-mail: [email protected].

    View full text